<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="editorial" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ketendo</journal-id><journal-title-group><journal-title xml:lang="ru">Клиническая и экспериментальная тиреоидология</journal-title><trans-title-group xml:lang="en"><trans-title>Clinical and experimental thyroidology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-5472</issn><issn pub-type="epub">2310-3787</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/ket12761</article-id><article-id custom-type="elpub" pub-id-type="custom">ketendo-12761</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Редакционная статья</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>Пресс-релиз с конгресса Общества эндокринологии ENDO 2022</article-title><trans-title-group xml:lang="en"><trans-title>Press release from the Endocrine Society ENDO 2022 Annual Conference</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Редакционная</surname><given-names>статья</given-names></name><name name-style="western" xml:lang="en"><surname>Editorial</surname><given-names>Article</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "НМИЦ эндокринологии" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Endocrinology Research Centre</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>31</day><month>07</month><year>2023</year></pub-date><volume>18</volume><issue>4</issue><fpage>23</fpage><lpage>24</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Редакционная с., 2023</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="ru">Редакционная с.</copyright-holder><copyright-holder xml:lang="en">Editorial A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.cet-endojournals.ru/jour/article/view/12761">https://www.cet-endojournals.ru/jour/article/view/12761</self-uri><abstract><p>В июне 2022 г. прошло ENDO 2022 — одно из ключевых международных мероприятий, посвященных эндокринным заболеваниям. В статье представлен краткий обзор клинической части мероприятия по вопросам заболеваний щитовидной железы.</p></abstract><trans-abstract xml:lang="en"><p>ENDO 2022 — the key international event dedicated to endocrine diseases — was held in June 2022. This article provides a brief overview of the event and is focused on the thyroid disease.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>щитовидная железа</kwd><kwd>рак щитовидной железы</kwd><kwd>левотироксин натрия</kwd><kwd>COVID-19</kwd></kwd-group><kwd-group xml:lang="en"><kwd>thyroid</kwd><kwd>thyroid cancer</kwd><kwd>levothyroxine</kwd><kwd>COVID-19</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Chou R, Dana T, Haymart M, et al. Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review. Thyroid. 2022;32(4):351-367. doi: https://doi.org/10.1089/thy.2021.0539</mixed-citation><mixed-citation xml:lang="en">Chou R, Dana T, Haymart M, et al. Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review. Thyroid. 2022;32(4):351-367. doi: https://doi.org/10.1089/thy.2021.0539</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Roman BR, Brito JP, Saucke MC, et al. National survey of endocrinologists and surgeons regarding active surveillance for low-risk papillary thyroid cancer. Endocr Pract. 2021;27(1):1-7. doi: https://doi.org/10.1016/j.eprac.2020.11.003</mixed-citation><mixed-citation xml:lang="en">Roman BR, Brito JP, Saucke MC, et al. National survey of endocrinologists and surgeons regarding active surveillance for low-risk papillary thyroid cancer. Endocr Pract. 2021;27(1):1-7. doi: https://doi.org/10.1016/j.eprac.2020.11.003</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tuttle RM, Fagin JA, Minkowitz G, et al. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance. JAMA Otolaryngol Head Neck Surg. 2017;143(10):1015-1020. doi: https://doi.org/10.1001/jamaoto.2017.1442</mixed-citation><mixed-citation xml:lang="en">Tuttle RM, Fagin JA, Minkowitz G, et al. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance. JAMA Otolaryngol Head Neck Surg. 2017;143(10):1015-1020. doi: https://doi.org/10.1001/jamaoto.2017.1442</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Nasr CE, Andriol M, Endo M, et al. LBSAT255 Real World Performance Of The Afirma Genomic Sequencing Classifier (GSC) — A Meta-analysis. J Endocr Soc. 2022;6(1):A745–A746. doi: https://doi.org/10.1210/jendso/bvac150.1538</mixed-citation><mixed-citation xml:lang="en">Nasr CE, Andriol M, Endo M, et al. LBSAT255 Real World Performance Of The Afirma Genomic Sequencing Classifier (GSC) — A Meta-analysis. J Endocr Soc. 2022;6(1):A745–A746. doi: https://doi.org/10.1210/jendso/bvac150.1538</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lui D, Lee CH, Cheung C, et al. LBODP093 Evaluation Of The Impact Of Covid-19 Vaccines On Thyroid Function And Autoimmunity And The Potential Influence Of Pre-existing Thyroid Autoimmunity On Neutralizing Antibody Responses. J Endocr Soc. 2022;6(1):A738. doi: https://doi.org/10.1210/jendso/bvac150.1523</mixed-citation><mixed-citation xml:lang="en">Lui D, Lee CH, Cheung C, et al. LBODP093 Evaluation Of The Impact Of Covid-19 Vaccines On Thyroid Function And Autoimmunity And The Potential Influence Of Pre-existing Thyroid Autoimmunity On Neutralizing Antibody Responses. J Endocr Soc. 2022;6(1):A738. doi: https://doi.org/10.1210/jendso/bvac150.1523</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chui C, Lau K, Lui D, et al. ODP514 Safety of Inactivated and mRNA COVID-19 Vaccination among Patients Treated for Hypothyroidism: a Population-based Cohort Study. J Endocr Soc. 2022;6(1):A780–A781. doi: https://doi.org/10.1210/jendso/bvac150.1614</mixed-citation><mixed-citation xml:lang="en">Chui C, Lau K, Lui D, et al. ODP514 Safety of Inactivated and mRNA COVID-19 Vaccination among Patients Treated for Hypothyroidism: a Population-based Cohort Study. J Endocr Soc. 2022;6(1):A780–A781. doi: https://doi.org/10.1210/jendso/bvac150.1614</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
